Ozempic and Mounjaro, originally diabetes medications, have exploded in popularity as powerful weight-loss injectables.

The first head-to-head trial of Mounjaro and Wegovy, the weight-loss drugs, compared the effectiveness of the two leading ...

One weight loss injection has been branded more effective than another, after scientists carry out the first ever ...

Both medications were prescribed as weekly injections for patients clinically classified as obese, and were recommended ...

The Royal College of GPs’ weight loss expert has sounded a warning bell for users of popular drugs Ozempic, Mounjaro and ...

Eventually, it was proven that Mounjaro is more affective than Wegovy in terms of weight loss, with 32 per cent of ...

Mounjaro has been found to be more effective than Wegovy in the first direct comparison trial of two major weight-loss drugs.

In the first head-to-head trial of its kind, people with obesity who took tirzepatide (sold under the brand names Mounjaro ...

The drug is set to be available on the NHS for weight loss soon, but one expert has flagged some potential risks that come with it.

Mounjaro, manufactured by US drugmaker, and Wegovy by Danish drugmaker Novo Nordisk, cause weight loss by suppressing the ...

Weight-loss jab Mounjaro helps people shed significantly more weight than rival Wegovy, new research suggests.

Landmark research suggests the appetite-suppressing jabs which mimic a hormone that makes us feel full also significantly cut ...